Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk


Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.

https://media-www.fapvoice.com/wp-content/uploads/2016/08/4.jpg